Baker Tilly Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
CAM
MSV
BST
BRCM
FFA
BAM
GI
EFG
RSC
BSB
Baker Tilly Wealth Management's IDXX Position: Q3 2026 in Review
Baker Tilly Wealth Management sold out of Idexx Laboratories (IDXX) in Q3 2026, closing a stake of 591 shares — an estimated $311K sold.
Baker Tilly Wealth Management first reported a position in IDXX in Q1 2021 and held it in 18 quarters. The position peaked at $838K in Q1 2023. 33 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Baker Tilly Wealth Management reported no remaining Idexx Laboratories position as of Q3 2026 after selling out during the quarter.
- Baker Tilly Wealth Management sold 591 Idexx Laboratories shares in Q3 2026, an estimated $311K.
- Baker Tilly Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and held it in 18 quarters.
- Baker Tilly Wealth Management's Idexx Laboratories position peaked at $838K in Q1 2023.
- 33 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Baker Tilly Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.